Rajeev A. Modi - 01 Mar 2024 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Reporting relationship: Executive Vice President U.S. Pet Health and Global Digital Transformation
Issuer ticker: ELAN
Reported as of: 01 Mar 2024
Net transaction value: -$57,964
SEC form: 4
Accepted by SEC: 05 Mar 2024, 16:27:57 UTC
Prior SEC filing: 27 Feb 2024
Next SEC filing: 12 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi

Key filing fact

Rajeev A. Modi filed Form 4 for Elanco Animal Health Inc (ELAN) on 05 Mar 2024.

Key facts

This page summarizes Rajeev A. Modi's Form 4 filing for Elanco Animal Health Inc (ELAN).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Mar 2024, 16:27.

Change

Previous filing in this sequence was filed on 27 Feb 2024.
Current net transaction value: -$57,964.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELAN transaction

Common Stock

Award

Transaction value: $0
Shares: +19,651
Change %: +32%
Price: $0.000000
Shares after: 80,888
Date: 01 Mar 2024
Ownership: Direct
Footnotes: F1, F2

ELAN transaction

Common Stock

Tax liability

Transaction value: $57,964
Shares: -3,616
Change %: -4.5%
Price: $16.03
Shares after: 77,272
Date: 01 Mar 2024
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELAN transaction Derivative

Employee Stock Option(right to buy)

Award

Transaction value: $0
Shares: +42,858
Change %
Price: $0.000000
Shares after: 42,858
Date: 01 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 42,858
Exercise price: $16.03
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2024, one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.

Footnote F2

Includes 1,588 shares acquired on June 30, 2023, and 802 shares acquired on September 29, 2023, under Elanco Animal Health Inc.'s Employee Stock Purchase Plan .

Footnote F3

Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.

Footnote F4

Grant of stock options vesting as follows: one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.

SEC remarks

Executive Vice President U.S. Pet Health and Global Digital Transformation